Gesynta Pharma
Sweden - Stockholm
PharmaceuticalFocus: mPGES-1 inhibition in cardiovascular diseases and cancer.
Gesynta Pharma is a life sciences company focused on mPGES-1 inhibition in cardiovascular diseases and cancer..
OncologyCardiovascularMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Formulation A GS-248
PharmacokineticClinical Trials (1)
NCT04617509A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248
Phase 1GS-248
HealthyClinical Trials (1)
NCT04036227Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248
Phase 1Vipoglanstat
EndometriosisClinical Trials (1)
NCT07260669A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2GS-248
Systemic SclerosisClinical Trials (1)
NCT04744207A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 4 clinical trials